NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

傳染性軟疣(MC)- 流行病學預測 2028年

Molluscum Contagiosum - Epidemiology Forecast - 2028

出版商 DelveInsight Business Research LLP 商品編碼 918182
出版日期 按訂單生產 內容資訊 英文 63 Pages
商品交期: 2-10個工作天內
價格
傳染性軟疣(MC)- 流行病學預測 2028年 Molluscum Contagiosum - Epidemiology Forecast - 2028
出版日期: 按訂單生產內容資訊: 英文 63 Pages
簡介

主要7個國家(美國,英國,德國,法國,義大利,西班牙,日本)的傳染性軟疣(MC)的2017年的患病數估算為1,216萬1,039人。

本報告提供主要7個國家(美國,英國,德國,法國,義大利,西班牙,日本)的傳染性軟疣(MC)市場相關調查,疾病概要,各國流行病學的預測,患病數的變化與預測等資料彙整。

目錄

第1章 重要洞察

第2章 傳染性軟疣(MC)市場概要

  • 傳染性軟疣(MC)的分佈(實數值)
  • 傳染性軟疣(MC)的分佈(預測值)

第3章 疾病概要

  • 簡介
  • 分類
  • 臨床性特徵
  • 遺傳學
  • 病理生理學
  • 診斷

第4章 流行病學和患者人口

  • 主要調查結果
  • 主要7個國家的傳染性軟疣(MC)的總患病數
  • 傳染性軟疣(MC)的流行病學預測:各國
  • 美國
    • 假設和理論性根據
    • 傳染性軟疣(MC)的總患病數
    • 傳染性軟疣(MC)的患病數:性別
    • 傳染性軟疣(MC)的患病數:各年齡
    • 傳染性軟疣(MC)的診斷數
    • 傳染性軟疣(MC)的病例數:各類型
  • 歐盟5國
    • 德國
      • 假設和理論性根據
      • 傳染性軟疣(MC)的總患病數
      • 傳染性軟疣(MC)的患病數:性別
      • 傳染性軟疣(MC)的患病數:各年齡
      • 傳染性軟疣(MC)的診斷數
      • 傳染性軟疣(MC)的病例數:各類型
    • 法國
    • 義大利
    • 西班牙
    • 英國
  • 日本
    • 假設和理論性根據
    • 傳染性軟疣(MC)的總患病數
    • 傳染性軟疣(MC)的患病數:性別
    • 傳染性軟疣(MC)的患病數:各年齡
    • 傳染性軟疣(MC)的診斷數
    • 傳染性軟疣(MC)的病例數:各類型

第5章 附錄

第6章 DelveInsight的服務內容

第7章 免責聲明

第8章 關於DelveInsight

目錄
Product Code: DIEI0398

DelveInsight's 'Molluscum Contagiosum- Epidemiology Forecast-2028' report deliver an in-depth understanding of the disease, historical & forecasted epidemiology trends of Molluscum Contagiosum in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2028

Molluscum Contagiosum - Disease Understanding

Molluscum Contagiosum (MC) is a common superficial skin infection caused by the poxvirus. It is characterized by painless white or skin-colored papular skin-lesions that are generally 2-5 mm in size, though early lesions can be smaller. The patients typically have 1-20 molluscum lesions, although even healthy patients may have a hundred or more lesions.

The virus is transmitted mainly by direct contact with infected skin, which can be sexual, nonsexual, or autoinoculation. It is common in children and generally presents with asymptomatic lesions; however, it can present with pruritus, erythema, and on some occasions, bacterial super infections with inflammation and pain. In normal hosts, MC is benign natured, limited to the skin, but lesions can take as long as 6-12 months to resolve. Immunocompromised patients can develop very large (>15 mm) and numerous lesions, and bacterial super infections

Molluscum Contagiosum - Epidemiology

The Molluscum Contagiosum epidemiology division provide insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Prevalence of Molluscum Contagiosum in 7MM, Gender-Specific Prevalence of Molluscum Contagiosum in 7MM, Age-Specific Prevalence of Molluscum Contagiosum), scenario of Molluscum Contagiosum in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2028.

DelveInsight's estimations suggests the total prevalent cases of Molluscum Contagiosum in the 7MM was found to be approximately 12,161,039 in 2017. Among 7MM, United States has the prevalent population of Molluscum Contagiosum with about 6,163,809 cases in 2017. In 2017 among EU-5 countries, UK has the highest prevalent cases with 1,066,107, followed by Germany with 950,724 cases. While, Spain has the least number of prevalent cases with approximately 678,589.

In 2017, the prevalent population of Molluscum Contagiosum in Japan was found to be approximately 1,584,927.

The MC predominately effects the children under the age of 15, however, recently, it has been observed that Adults with HIV infection or immunocompromised patients are also added to the prevalent pool, which is now making MC as Children and Adult-specific disease. Among the Children-specific cases, US has the highest number of patients with 6,113,396 in 2017 and Adult-specific cases are reported around 50,413.

Molluscum Contagiosum Report Insights

  • The report covers a descriptive overview of the Molluscum Contagiosum, explaining its causes, risk factors, pathophysiology and diagnosis.
  • Comprehensive insight has been provided into the epidemiology Molluscum Contagiosum in the 7MM countries covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • Assesses growth opportunities in the 7MM countries with respect to the patient population.

Molluscum Contagiosum Report Key Strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Patient Pool with Molluscum Contagiosum
  • Age-Specific Diagnosed Patient Pool of Molluscum Contagiosum
  • Gender-Specific Diagnosed Patient Pool of Molluscum Contagiosum

Molluscum Contagiosum Report Assessment

  • Current Treatment Practices
  • Unmet Needs
  • Detailed Pipeline Product Profiles

Key Benefits

  • Key assessments
  • Patient Segmentation
  • Disease Risk & Burden

Table of Contents

1. Key Insights

2. Molluscum Contagiosum: Patient Overview at a Glance

  • 2.1. Patient Share (%) Distribution of Molluscum Contagiosum in 2017
  • 2.2. Patient Share (%) Distribution of Molluscum Contagiosum in 2028

3. Disease Overview: Molluscum Contagiosum

  • 3.1. Introduction
  • 3.2. Classification
  • 3.3. Clinical features
  • 3.4. Genetics
  • 3.5. Pathophysiology
  • 3.6. Diagnosis

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. 7MM Total Prevalent Patient Population of Molluscum Contagiosum
  • 4.3. Country Wise-Epidemiology of Molluscum Contagiosum
  • 4.4. United States
    • 4.4.1. Assumptions and Rationale
    • 4.4.2. Prevalent Cases of Molluscum Contagiosum in the United States
    • 4.4.3. Gender-Specific Cases of Molluscum Contagiosum in the United States
    • 4.4.4. Age-Specific Cases of Molluscum Contagiosum in the United States
    • 4.4.5. Diagnosed Cases of Molluscum Contagiosum in the United States
    • 4.4.6. Type-Specific Cases of Molluscum Contagiosum in the United States
  • 4.5. EU5
    • 4.5.1. Assumptions and Rationale
  • 4.6. Germany
    • 4.6.1. Prevalent Cases of Molluscum Contagiosum in Germany
    • 4.6.2. Gender-Specific Cases of Molluscum Contagiosum in Germany
    • 4.6.3. Age-Specific Cases of Molluscum Contagiosum in Germany
    • 4.6.4. Diagnosed Cases of Molluscum Contagiosum in Germany
    • 4.6.5. Type-Specific Diagnosed Cases of Molluscum Contagiosum in Germany
  • 4.7. France
    • 4.7.1. Prevalent Cases of Molluscum Contagiosum in France
    • 4.7.2. Gender-Specific Cases of Molluscum Contagiosum in France
    • 4.7.3. Age-Specific Cases of Molluscum Contagiosum in France
    • 4.7.4. Diagnosed Cases of Molluscum Contagiosum in France
    • 4.7.5. Type-Specific Cases of Molluscum Contagiosum in France
  • 4.8. Italy
    • 4.8.1. Prevalent Cases of Molluscum Contagiosum in Italy
    • 4.8.2. Gender-Specific Cases of Molluscum Contagiosum in Italy
    • 4.8.3. Age-Specific Cases of Molluscum Contagiosum in Italy
    • 4.8.4. Diagnosed Cases of Molluscum Contagiosum in Italy
    • 4.8.5. Type-Specific Cases of Molluscum Contagiosum in Italy
  • 4.9. Spain
    • 4.9.1. Prevalent Cases of Molluscum Contagiosum in Spain
    • 4.9.2. Gender-Specific Cases of Molluscum Contagiosum in Spain
    • 4.9.3. Age-Specific Cases of Molluscum Contagiosum in Spain
    • 4.9.4. Diagnosed Cases of Molluscum Contagiosum in Spain
    • 4.9.5. Type-Specific Cases of Molluscum Contagiosum in Spain
  • 4.10. United Kingdom
    • 4.10.1. Prevalent Cases of Molluscum Contagiosum in United Kingdom
    • 4.10.2. Gender-Specific Cases of Molluscum Contagiosum in the United Kingdom
    • 4.10.3. Age-Specific Cases of Molluscum Contagiosum in the United Kingdom
    • 4.10.4. Diagnosed Cases of Molluscum Contagiosum in the United Kingdom
    • 4.10.5. Type-Specific Diagnosed Cases of Molluscum Contagiosum in the United Kingdom
  • 4.11. Japan
    • 4.11.1. Assumptions and Rationale
    • 4.11.2. Prevalent Cases of Molluscum Contagiosum in Japan
    • 4.11.3. Gender-Specific Cases of Molluscum Contagiosum in Japan
    • 4.11.4. Age-Specific Cases of Molluscum Contagiosum in Japan
    • 4.11.5. Diagnosed Cases of Molluscum Contagiosum in Japan
    • 4.11.6. Type-Specific Diagnosed Cases of Molluscum Contagiosum in Japan

5. Appendix

  • 5.1. Report Methodology

6. DelveInsight Capabilities

7. Disclaimer

8. About DelveInsight

List of Tables

  • Table 1: Defense mechanisms used by Molluscum contagiosum virus to avoid immunologic reactions
  • Table 2: Molluscum contagiosum differential diagnosis
  • Table 3: Total Prevalent cases of Molluscum Contagiosum in 7MM (2017-2028)
  • Table 4: Total Prevalent Cases of Molluscum Contagiosum in the US (2017-2028)
  • Table 5: Age-Specific Prevalent Cases of Molluscum Contagiosum in the US (2017-2028)
  • Table 6: Gender-Specific Prevalent Cases of Molluscum Contagiosum in the US (2017-2028)
  • Table 7: Total Prevalent Cases of Molluscum Contagiosum in Germany (2017-2028)
  • Table 8: Age-Specific Prevalent Cases of Molluscum Contagiosum in Germany (2017-2028)
  • Table 9: Gender-Specific Prevalent Cases of Molluscum Contagiosum in Germany (2017-2028)
  • Table 10: Total Prevalent Cases of Molluscum Contagiosum in France (2017-2028)
  • Table 11: Age-Specific Prevalent Cases of Molluscum Contagiosum in France (2017-2028)
  • Table 12: Gender-Specific Prevalent Cases of Molluscum Contagiosum in France (2017-2028)
  • Table 13: Total Prevalent Cases of Molluscum Contagiosum in Italy (2017-2028)
  • Table 14: Age-Specific Prevalent Cases of Molluscum Contagiosum in Italy (2017-2028)
  • Table 15: Gender-Specific Prevalent Cases of Molluscum Contagiosum in Italy (2017-2028)
  • Table 16: Total Prevalent Cases of Molluscum Contagiosum in Spain (2017-2028)
  • Table 17: Age-Specific Prevalent Cases of Molluscum Contagiosum in Spain (2017-2028)
  • Table 18: Gender-Specific Prevalent Cases of Molluscum Contagiosum in Spain (2017-2028)
  • Table 19: Total Prevalent Cases of Molluscum Contagiosum in the UK (2017-2028)
  • Table 20: Age-Specific Prevalent Cases of Molluscum Contagiosum in the UK (2017-2028)
  • Table 21: Gender-Specific Prevalent Cases of Molluscum Contagiosum in the UK (2017-2028)
  • Table 22: Total Prevalent Cases of Molluscum Contagiosum in Japan (2017-2028)
  • Table 23: Age-Specific Prevalent Cases of Molluscum Contagiosum in Japan (2017-2028)
  • Table 24: Gender-Specific Prevalent Cases of Molluscum Contagiosum in Japan (2017-2028)

List of Figures

  • Figure 1: Epidemiology and Market Methodology
  • Figure 2: Causes of Molluscum contagiosum
  • Figure 3: Signs and symptoms of Molluscum contagiosum include bumps on the skin
  • Figure 4: Dermatoscopic findings of MC
  • Figure 5: Total Prevalent cases of Molluscum Contagiosum in 7MM (2017-2028)
  • Figure 6: Total Diagnosed Prevalent Cases of Molluscum Contagiosum in the US (2017-2028)
  • Figure 7: Age-Specific Prevalent Cases of Molluscum Contagiosum in the US (2017-2028)
  • Figure 8: Gender-Specific Cases of Molluscum Contagiosum in the US (2017-2028)
  • Figure 9: Total Prevalent Cases of Molluscum Contagiosum in Germany (2017-2028)
  • Figure 10: Age-Specific Prevalent Cases of Molluscum Contagiosum in Germany (2017-2028)
  • Figure 11: Gender-Specific Cases of Molluscum Contagiosum in Germany (2017-2028)
  • Figure 12: Total Prevalent Cases of Molluscum Contagiosum in France (2017-2028)
  • Figure 13: Age-Specific Prevalent Cases of Molluscum Contagiosum in France (2017-2028)
  • Figure 14: Gender-Specific Cases of Molluscum Contagiosum in France (2017-2028)
  • Figure 15: Total Prevalent Cases of Molluscum Contagiosum in Italy (2017-2028)
  • Figure 16: Age-Specific Prevalent Cases of Molluscum Contagiosum in Italy (2017-2028)
  • Figure 17: Gender-Specific Cases of Molluscum Contagiosum in Italy (2017-2028)
  • Figure 18: Total Prevalent Cases of Molluscum Contagiosum in Spain (2017-2028)
  • Figure 19: Age-Specific Prevalent Cases of Molluscum Contagiosum in Spain (2017-2028)
  • Figure 20: Gender-Specific Cases of Molluscum Contagiosum in Spain (2017-2028)
  • Figure 21: Total Prevalent Cases of Molluscum Contagiosum in the UK (2017-2028)
  • Figure 22: Age-Specific Prevalent Cases of Molluscum Contagiosum in the UK (2017-2028)
  • Figure 23: Gender-Specific Cases of Molluscum Contagiosum in the UK (2017-2028)
  • Figure 24: Total Prevalent Cases of Molluscum Contagiosum in Japan (2017-2028)
  • Figure 25: Age-Specific Prevalent Cases of Molluscum Contagiosum in Japan (2017-2028)
  • Figure 26: Gender-Specific Cases of Molluscum Contagiosum in Japan (2017-2028)